nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—Hyperthyroidism—Levothyroxine—hypothyroidism	0.00914	0.0422	CcSEcCtD
Sunitinib—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.00914	0.0422	CcSEcCtD
Sunitinib—Hyperthyroidism—Liotrix—hypothyroidism	0.00672	0.0311	CcSEcCtD
Sunitinib—Intestinal perforation—Liotrix—hypothyroidism	0.00672	0.0311	CcSEcCtD
Sunitinib—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00589	0.0272	CcSEcCtD
Sunitinib—Hypernatraemia—Liotrix—hypothyroidism	0.00505	0.0234	CcSEcCtD
Sunitinib—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00406	0.0187	CcSEcCtD
Sunitinib—Abscess—Liotrix—hypothyroidism	0.00336	0.0155	CcSEcCtD
Sunitinib—Arrhythmia—Liothyronine—hypothyroidism	0.0033	0.0153	CcSEcCtD
Sunitinib—Cellulitis—Liotrix—hypothyroidism	0.00292	0.0135	CcSEcCtD
Sunitinib—Hypocalcaemia—Liotrix—hypothyroidism	0.0029	0.0134	CcSEcCtD
Sunitinib—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00289	0.0134	CcSEcCtD
Sunitinib—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00289	0.0134	CcSEcCtD
Sunitinib—Creatinine increased—Liotrix—hypothyroidism	0.00279	0.0129	CcSEcCtD
Sunitinib—Hypertension—Liothyronine—hypothyroidism	0.00278	0.0128	CcSEcCtD
Sunitinib—Cardiac failure—Levothyroxine—hypothyroidism	0.00269	0.0124	CcSEcCtD
Sunitinib—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00269	0.0124	CcSEcCtD
Sunitinib—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00269	0.0124	CcSEcCtD
Sunitinib—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00269	0.0124	CcSEcCtD
Sunitinib—Dehydration—Dextrothyroxine—hypothyroidism	0.00244	0.0113	CcSEcCtD
Sunitinib—Dehydration—Levothyroxine—hypothyroidism	0.00244	0.0113	CcSEcCtD
Sunitinib—Muscular weakness—Levothyroxine—hypothyroidism	0.00231	0.0107	CcSEcCtD
Sunitinib—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00231	0.0107	CcSEcCtD
Sunitinib—Sepsis—Liotrix—hypothyroidism	0.00231	0.0107	CcSEcCtD
Sunitinib—Dysphagia—Dextrothyroxine—hypothyroidism	0.00227	0.0105	CcSEcCtD
Sunitinib—Dysphagia—Levothyroxine—hypothyroidism	0.00227	0.0105	CcSEcCtD
Sunitinib—Cardiac failure congestive—Liotrix—hypothyroidism	0.00213	0.00983	CcSEcCtD
Sunitinib—Renal failure acute—Liotrix—hypothyroidism	0.00209	0.00966	CcSEcCtD
Sunitinib—Body temperature increased—Liothyronine—hypothyroidism	0.00207	0.00959	CcSEcCtD
Sunitinib—Weight decreased—Levothyroxine—hypothyroidism	0.00205	0.00948	CcSEcCtD
Sunitinib—Weight decreased—Dextrothyroxine—hypothyroidism	0.00205	0.00948	CcSEcCtD
Sunitinib—Renal impairment—Liotrix—hypothyroidism	0.00203	0.00937	CcSEcCtD
Sunitinib—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00199	0.00921	CcSEcCtD
Sunitinib—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00199	0.00921	CcSEcCtD
Sunitinib—Hypoglycaemia—Liotrix—hypothyroidism	0.00198	0.00914	CcSEcCtD
Sunitinib—Cardiac failure—Liotrix—hypothyroidism	0.00198	0.00914	CcSEcCtD
Sunitinib—Cerebrovascular accident—Liotrix—hypothyroidism	0.00197	0.0091	CcSEcCtD
Sunitinib—Blood creatinine increased—Liotrix—hypothyroidism	0.00181	0.00835	CcSEcCtD
Sunitinib—Dehydration—Liotrix—hypothyroidism	0.00179	0.00829	CcSEcCtD
Sunitinib—Hypokalaemia—Liotrix—hypothyroidism	0.00176	0.00811	CcSEcCtD
Sunitinib—Muscular weakness—Liotrix—hypothyroidism	0.0017	0.00786	CcSEcCtD
Sunitinib—Flushing—Levothyroxine—hypothyroidism	0.00168	0.00778	CcSEcCtD
Sunitinib—Flushing—Dextrothyroxine—hypothyroidism	0.00168	0.00778	CcSEcCtD
Sunitinib—Abdominal distension—Liotrix—hypothyroidism	0.00168	0.00776	CcSEcCtD
Sunitinib—Dysphagia—Liotrix—hypothyroidism	0.00167	0.00771	CcSEcCtD
Sunitinib—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00162	0.00749	CcSEcCtD
Sunitinib—Arrhythmia—Levothyroxine—hypothyroidism	0.00162	0.00749	CcSEcCtD
Sunitinib—Bronchitis—Liotrix—hypothyroidism	0.0016	0.00741	CcSEcCtD
Sunitinib—Alopecia—Dextrothyroxine—hypothyroidism	0.0016	0.00741	CcSEcCtD
Sunitinib—Alopecia—Levothyroxine—hypothyroidism	0.0016	0.00741	CcSEcCtD
Sunitinib—Weight decreased—Liotrix—hypothyroidism	0.00151	0.00697	CcSEcCtD
Sunitinib—Acute coronary syndrome—Liotrix—hypothyroidism	0.00147	0.00677	CcSEcCtD
Sunitinib—Renal failure—Liotrix—hypothyroidism	0.00146	0.00675	CcSEcCtD
Sunitinib—Angioedema—Levothyroxine—hypothyroidism	0.00144	0.00667	CcSEcCtD
Sunitinib—Angioedema—Dextrothyroxine—hypothyroidism	0.00144	0.00667	CcSEcCtD
Sunitinib—Convulsion—Dextrothyroxine—hypothyroidism	0.00137	0.00632	CcSEcCtD
Sunitinib—Convulsion—Levothyroxine—hypothyroidism	0.00137	0.00632	CcSEcCtD
Sunitinib—Arthralgia—Levothyroxine—hypothyroidism	0.00134	0.00621	CcSEcCtD
Sunitinib—Arthralgia—Dextrothyroxine—hypothyroidism	0.00134	0.00621	CcSEcCtD
Sunitinib—Hypoaesthesia—Liotrix—hypothyroidism	0.00133	0.00614	CcSEcCtD
Sunitinib—Shock—Levothyroxine—hypothyroidism	0.00127	0.00586	CcSEcCtD
Sunitinib—Shock—Dextrothyroxine—hypothyroidism	0.00127	0.00586	CcSEcCtD
Sunitinib—Flushing—Liotrix—hypothyroidism	0.00124	0.00572	CcSEcCtD
Sunitinib—Arrhythmia—Liotrix—hypothyroidism	0.00119	0.00551	CcSEcCtD
Sunitinib—Alopecia—Liotrix—hypothyroidism	0.00118	0.00545	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00117	0.00543	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00117	0.00543	CcSEcCtD
Sunitinib—Insomnia—Dextrothyroxine—hypothyroidism	0.00117	0.00539	CcSEcCtD
Sunitinib—Insomnia—Levothyroxine—hypothyroidism	0.00117	0.00539	CcSEcCtD
Sunitinib—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00115	0.00531	CcSEcCtD
Sunitinib—Dyspnoea—Levothyroxine—hypothyroidism	0.00115	0.00531	CcSEcCtD
Sunitinib—Flatulence—Liotrix—hypothyroidism	0.00114	0.00529	CcSEcCtD
Sunitinib—Dysgeusia—Liotrix—hypothyroidism	0.00114	0.00526	CcSEcCtD
Sunitinib—Fatigue—Dextrothyroxine—hypothyroidism	0.00111	0.00514	CcSEcCtD
Sunitinib—Fatigue—Levothyroxine—hypothyroidism	0.00111	0.00514	CcSEcCtD
Sunitinib—Angioedema—Liotrix—hypothyroidism	0.00106	0.00491	CcSEcCtD
Sunitinib—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00105	0.00487	CcSEcCtD
Sunitinib—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00105	0.00487	CcSEcCtD
Sunitinib—Abdominal pain—Levothyroxine—hypothyroidism	0.00102	0.00471	CcSEcCtD
Sunitinib—Body temperature increased—Levothyroxine—hypothyroidism	0.00102	0.00471	CcSEcCtD
Sunitinib—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00102	0.00471	CcSEcCtD
Sunitinib—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00102	0.00471	CcSEcCtD
Sunitinib—Convulsion—Liotrix—hypothyroidism	0.00101	0.00465	CcSEcCtD
Sunitinib—Hypertension—Liotrix—hypothyroidism	0.001	0.00464	CcSEcCtD
Sunitinib—Chest pain—Liotrix—hypothyroidism	0.000989	0.00457	CcSEcCtD
Sunitinib—Arthralgia—Liotrix—hypothyroidism	0.000989	0.00457	CcSEcCtD
Sunitinib—Oedema—Liotrix—hypothyroidism	0.000948	0.00438	CcSEcCtD
Sunitinib—Infection—Liotrix—hypothyroidism	0.000942	0.00435	CcSEcCtD
Sunitinib—Shock—Liotrix—hypothyroidism	0.000933	0.00431	CcSEcCtD
Sunitinib—Asthenia—Levothyroxine—hypothyroidism	0.000925	0.00427	CcSEcCtD
Sunitinib—Asthenia—Dextrothyroxine—hypothyroidism	0.000925	0.00427	CcSEcCtD
Sunitinib—Pruritus—Dextrothyroxine—hypothyroidism	0.000912	0.00421	CcSEcCtD
Sunitinib—Pruritus—Levothyroxine—hypothyroidism	0.000912	0.00421	CcSEcCtD
Sunitinib—Anorexia—Liotrix—hypothyroidism	0.000904	0.00418	CcSEcCtD
Sunitinib—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000882	0.00408	CcSEcCtD
Sunitinib—Diarrhoea—Levothyroxine—hypothyroidism	0.000882	0.00408	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000864	0.00399	CcSEcCtD
Sunitinib—Insomnia—Liotrix—hypothyroidism	0.000858	0.00396	CcSEcCtD
Sunitinib—Paraesthesia—Liotrix—hypothyroidism	0.000851	0.00393	CcSEcCtD
Sunitinib—Dyspnoea—Liotrix—hypothyroidism	0.000845	0.00391	CcSEcCtD
Sunitinib—Decreased appetite—Liotrix—hypothyroidism	0.000824	0.00381	CcSEcCtD
Sunitinib—Vomiting—Dextrothyroxine—hypothyroidism	0.00082	0.00379	CcSEcCtD
Sunitinib—Vomiting—Levothyroxine—hypothyroidism	0.00082	0.00379	CcSEcCtD
Sunitinib—Fatigue—Liotrix—hypothyroidism	0.000817	0.00378	CcSEcCtD
Sunitinib—Rash—Levothyroxine—hypothyroidism	0.000813	0.00376	CcSEcCtD
Sunitinib—Rash—Dextrothyroxine—hypothyroidism	0.000813	0.00376	CcSEcCtD
Sunitinib—Dermatitis—Dextrothyroxine—hypothyroidism	0.000812	0.00375	CcSEcCtD
Sunitinib—Dermatitis—Levothyroxine—hypothyroidism	0.000812	0.00375	CcSEcCtD
Sunitinib—Constipation—Liotrix—hypothyroidism	0.000811	0.00375	CcSEcCtD
Sunitinib—Headache—Dextrothyroxine—hypothyroidism	0.000807	0.00373	CcSEcCtD
Sunitinib—Headache—Levothyroxine—hypothyroidism	0.000807	0.00373	CcSEcCtD
Sunitinib—Gastrointestinal pain—Liotrix—hypothyroidism	0.000775	0.00358	CcSEcCtD
Sunitinib—Nausea—Dextrothyroxine—hypothyroidism	0.000766	0.00354	CcSEcCtD
Sunitinib—Nausea—Levothyroxine—hypothyroidism	0.000766	0.00354	CcSEcCtD
Sunitinib—Body temperature increased—Liotrix—hypothyroidism	0.00075	0.00346	CcSEcCtD
Sunitinib—Abdominal pain—Liotrix—hypothyroidism	0.00075	0.00346	CcSEcCtD
Sunitinib—Hypersensitivity—Liotrix—hypothyroidism	0.000699	0.00323	CcSEcCtD
Sunitinib—Asthenia—Liotrix—hypothyroidism	0.00068	0.00314	CcSEcCtD
Sunitinib—Pruritus—Liotrix—hypothyroidism	0.000671	0.0031	CcSEcCtD
Sunitinib—Diarrhoea—Liotrix—hypothyroidism	0.000649	0.003	CcSEcCtD
Sunitinib—Dizziness—Liotrix—hypothyroidism	0.000627	0.0029	CcSEcCtD
Sunitinib—Vomiting—Liotrix—hypothyroidism	0.000603	0.00279	CcSEcCtD
Sunitinib—Rash—Liotrix—hypothyroidism	0.000598	0.00276	CcSEcCtD
Sunitinib—Dermatitis—Liotrix—hypothyroidism	0.000597	0.00276	CcSEcCtD
Sunitinib—Headache—Liotrix—hypothyroidism	0.000594	0.00275	CcSEcCtD
Sunitinib—Nausea—Liotrix—hypothyroidism	0.000563	0.0026	CcSEcCtD
Sunitinib—IRAK1—female gonad—hypothyroidism	0.000292	0.000608	CbGeAlD
Sunitinib—MAP2K1—liver—hypothyroidism	0.000291	0.000608	CbGeAlD
Sunitinib—FLT3—cerebellum—hypothyroidism	0.000291	0.000606	CbGeAlD
Sunitinib—MAP3K12—cerebellum—hypothyroidism	0.000291	0.000606	CbGeAlD
Sunitinib—FGFR2—adrenal gland—hypothyroidism	0.00029	0.000604	CbGeAlD
Sunitinib—PRKAA1—testis—hypothyroidism	0.00029	0.000604	CbGeAlD
Sunitinib—FGFR2—blood—hypothyroidism	0.00029	0.000604	CbGeAlD
Sunitinib—PDGFRA—gonad—hypothyroidism	0.000289	0.000602	CbGeAlD
Sunitinib—JAK2—adrenal gland—hypothyroidism	0.000288	0.000601	CbGeAlD
Sunitinib—JAK2—blood—hypothyroidism	0.000288	0.000601	CbGeAlD
Sunitinib—CSNK1A1—liver—hypothyroidism	0.000288	0.0006	CbGeAlD
Sunitinib—YES1—pituitary gland—hypothyroidism	0.000287	0.000599	CbGeAlD
Sunitinib—KDR—cardiovascular system—hypothyroidism	0.000287	0.000599	CbGeAlD
Sunitinib—MAP2K5—cardiovascular system—hypothyroidism	0.000287	0.000599	CbGeAlD
Sunitinib—RPS6KA3—cerebellum—hypothyroidism	0.000287	0.000598	CbGeAlD
Sunitinib—PTK2B—testis—hypothyroidism	0.000287	0.000597	CbGeAlD
Sunitinib—RPS6KB1—female gonad—hypothyroidism	0.000286	0.000597	CbGeAlD
Sunitinib—CLK1—liver—hypothyroidism	0.000286	0.000596	CbGeAlD
Sunitinib—FLT4—testis—hypothyroidism	0.000286	0.000596	CbGeAlD
Sunitinib—MAP2K1—cerebellum—hypothyroidism	0.000285	0.000594	CbGeAlD
Sunitinib—FGR—female gonad—hypothyroidism	0.000285	0.000593	CbGeAlD
Sunitinib—FYN—adrenal gland—hypothyroidism	0.000284	0.000593	CbGeAlD
Sunitinib—FYN—blood—hypothyroidism	0.000284	0.000593	CbGeAlD
Sunitinib—TAOK3—pituitary gland—hypothyroidism	0.000284	0.000591	CbGeAlD
Sunitinib—AXL—female gonad—hypothyroidism	0.000283	0.000591	CbGeAlD
Sunitinib—SLK—thyroid gland—hypothyroidism	0.000282	0.000588	CbGeAlD
Sunitinib—CSNK1E—testis—hypothyroidism	0.000282	0.000588	CbGeAlD
Sunitinib—FGFR1—testis—hypothyroidism	0.000282	0.000588	CbGeAlD
Sunitinib—CSNK1A1—cerebellum—hypothyroidism	0.000281	0.000586	CbGeAlD
Sunitinib—BMP2K—liver—hypothyroidism	0.000281	0.000585	CbGeAlD
Sunitinib—CAMK2G—liver—hypothyroidism	0.000281	0.000585	CbGeAlD
Sunitinib—CSF1R—cardiovascular system—hypothyroidism	0.00028	0.000584	CbGeAlD
Sunitinib—FGFR2—thyroid gland—hypothyroidism	0.00028	0.000583	CbGeAlD
Sunitinib—CLK1—cerebellum—hypothyroidism	0.000279	0.000582	CbGeAlD
Sunitinib—JAK2—thyroid gland—hypothyroidism	0.000278	0.00058	CbGeAlD
Sunitinib—LRRK2—liver—hypothyroidism	0.000278	0.00058	CbGeAlD
Sunitinib—MAP4K5—adrenal gland—hypothyroidism	0.000278	0.000579	CbGeAlD
Sunitinib—MAP3K3—adrenal gland—hypothyroidism	0.000278	0.000579	CbGeAlD
Sunitinib—MAP3K3—blood—hypothyroidism	0.000278	0.000579	CbGeAlD
Sunitinib—MAP4K5—blood—hypothyroidism	0.000278	0.000579	CbGeAlD
Sunitinib—IRAK4—testis—hypothyroidism	0.000278	0.000579	CbGeAlD
Sunitinib—FYN—thyroid gland—hypothyroidism	0.000274	0.000572	CbGeAlD
Sunitinib—CAMK2G—cerebellum—hypothyroidism	0.000274	0.000571	CbGeAlD
Sunitinib—BMP2K—cerebellum—hypothyroidism	0.000274	0.000571	CbGeAlD
Sunitinib—PRKAA1—liver—hypothyroidism	0.000274	0.000571	CbGeAlD
Sunitinib—SLK—female gonad—hypothyroidism	0.000273	0.000569	CbGeAlD
Sunitinib—PDGFRB—adrenal cortex—hypothyroidism	0.000272	0.000568	CbGeAlD
Sunitinib—LRRK2—cerebellum—hypothyroidism	0.000272	0.000566	CbGeAlD
Sunitinib—MAP2K2—testis—hypothyroidism	0.000271	0.000566	CbGeAlD
Sunitinib—ULK3—testis—hypothyroidism	0.000271	0.000566	CbGeAlD
Sunitinib—PTK2B—liver—hypothyroidism	0.000271	0.000565	CbGeAlD
Sunitinib—FGFR2—female gonad—hypothyroidism	0.00027	0.000563	CbGeAlD
Sunitinib—FLT4—liver—hypothyroidism	0.00027	0.000563	CbGeAlD
Sunitinib—KIT—heart—hypothyroidism	0.00027	0.000562	CbGeAlD
Sunitinib—MAP3K2—testis—hypothyroidism	0.000269	0.000562	CbGeAlD
Sunitinib—JAK2—female gonad—hypothyroidism	0.000269	0.000561	CbGeAlD
Sunitinib—FLT1—adrenal gland—hypothyroidism	0.000269	0.00056	CbGeAlD
Sunitinib—FLT1—blood—hypothyroidism	0.000269	0.00056	CbGeAlD
Sunitinib—MAP4K5—thyroid gland—hypothyroidism	0.000268	0.000559	CbGeAlD
Sunitinib—MAP3K3—thyroid gland—hypothyroidism	0.000268	0.000559	CbGeAlD
Sunitinib—PRKAA1—cerebellum—hypothyroidism	0.000268	0.000558	CbGeAlD
Sunitinib—MAP3K7—testis—hypothyroidism	0.000267	0.000556	CbGeAlD
Sunitinib—CSNK1E—liver—hypothyroidism	0.000267	0.000556	CbGeAlD
Sunitinib—FGFR1—liver—hypothyroidism	0.000267	0.000556	CbGeAlD
Sunitinib—EPHB6—adrenal gland—hypothyroidism	0.000266	0.000554	CbGeAlD
Sunitinib—EPHB6—blood—hypothyroidism	0.000266	0.000554	CbGeAlD
Sunitinib—FYN—female gonad—hypothyroidism	0.000265	0.000553	CbGeAlD
Sunitinib—PTK2B—cerebellum—hypothyroidism	0.000265	0.000552	CbGeAlD
Sunitinib—TBK1—testis—hypothyroidism	0.000264	0.00055	CbGeAlD
Sunitinib—PDGFRB—heart—hypothyroidism	0.000263	0.000549	CbGeAlD
Sunitinib—IRAK4—liver—hypothyroidism	0.000262	0.000547	CbGeAlD
Sunitinib—TYK2—testis—hypothyroidism	0.000262	0.000546	CbGeAlD
Sunitinib—CSNK1E—cerebellum—hypothyroidism	0.00026	0.000543	CbGeAlD
Sunitinib—FGFR1—cerebellum—hypothyroidism	0.00026	0.000543	CbGeAlD
Sunitinib—FLT1—thyroid gland—hypothyroidism	0.000259	0.000541	CbGeAlD
Sunitinib—MAP4K5—female gonad—hypothyroidism	0.000259	0.00054	CbGeAlD
Sunitinib—MAP3K3—female gonad—hypothyroidism	0.000259	0.00054	CbGeAlD
Sunitinib—IRAK1—testis—hypothyroidism	0.000259	0.000539	CbGeAlD
Sunitinib—YES1—adrenal gland—hypothyroidism	0.000257	0.000535	CbGeAlD
Sunitinib—YES1—blood—hypothyroidism	0.000257	0.000535	CbGeAlD
Sunitinib—MAP2K2—liver—hypothyroidism	0.000257	0.000535	CbGeAlD
Sunitinib—ULK3—liver—hypothyroidism	0.000257	0.000535	CbGeAlD
Sunitinib—IRAK4—cerebellum—hypothyroidism	0.000256	0.000534	CbGeAlD
Sunitinib—EPHB6—thyroid gland—hypothyroidism	0.000256	0.000534	CbGeAlD
Sunitinib—MAP3K2—liver—hypothyroidism	0.000255	0.000531	CbGeAlD
Sunitinib—KIT—cardiovascular system—hypothyroidism	0.000255	0.000531	CbGeAlD
Sunitinib—STK10—adrenal gland—hypothyroidism	0.000254	0.00053	CbGeAlD
Sunitinib—CSF1R—gonad—hypothyroidism	0.000254	0.00053	CbGeAlD
Sunitinib—STK10—blood—hypothyroidism	0.000254	0.00053	CbGeAlD
Sunitinib—KDR—pituitary gland—hypothyroidism	0.000254	0.00053	CbGeAlD
Sunitinib—MAP2K5—pituitary gland—hypothyroidism	0.000254	0.00053	CbGeAlD
Sunitinib—RPS6KB1—testis—hypothyroidism	0.000254	0.000529	CbGeAlD
Sunitinib—TAOK3—adrenal gland—hypothyroidism	0.000253	0.000528	CbGeAlD
Sunitinib—TAOK3—blood—hypothyroidism	0.000253	0.000528	CbGeAlD
Sunitinib—MAP3K7—liver—hypothyroidism	0.000252	0.000526	CbGeAlD
Sunitinib—FGR—testis—hypothyroidism	0.000252	0.000526	CbGeAlD
Sunitinib—RET—testis—hypothyroidism	0.000252	0.000526	CbGeAlD
Sunitinib—PDGFRA—adrenal gland—hypothyroidism	0.000252	0.000525	CbGeAlD
Sunitinib—PDGFRA—blood—hypothyroidism	0.000252	0.000525	CbGeAlD
Sunitinib—AXL—testis—hypothyroidism	0.000251	0.000524	CbGeAlD
Sunitinib—ULK3—cerebellum—hypothyroidism	0.000251	0.000523	CbGeAlD
Sunitinib—MAP2K2—cerebellum—hypothyroidism	0.000251	0.000523	CbGeAlD
Sunitinib—FLT1—female gonad—hypothyroidism	0.000251	0.000522	CbGeAlD
Sunitinib—TBK1—liver—hypothyroidism	0.00025	0.00052	CbGeAlD
Sunitinib—MAP3K2—cerebellum—hypothyroidism	0.000249	0.000519	CbGeAlD
Sunitinib—PDGFRB—cardiovascular system—hypothyroidism	0.000249	0.000518	CbGeAlD
Sunitinib—CSF1R—pituitary gland—hypothyroidism	0.000248	0.000517	CbGeAlD
Sunitinib—TYK2—liver—hypothyroidism	0.000248	0.000517	CbGeAlD
Sunitinib—YES1—thyroid gland—hypothyroidism	0.000248	0.000516	CbGeAlD
Sunitinib—EPHB6—female gonad—hypothyroidism	0.000248	0.000516	CbGeAlD
Sunitinib—MAP3K7—cerebellum—hypothyroidism	0.000247	0.000514	CbGeAlD
Sunitinib—STK10—thyroid gland—hypothyroidism	0.000245	0.000512	CbGeAlD
Sunitinib—IRAK1—liver—hypothyroidism	0.000245	0.00051	CbGeAlD
Sunitinib—TAOK3—thyroid gland—hypothyroidism	0.000245	0.00051	CbGeAlD
Sunitinib—TBK1—cerebellum—hypothyroidism	0.000244	0.000508	CbGeAlD
Sunitinib—PDGFRA—thyroid gland—hypothyroidism	0.000243	0.000507	CbGeAlD
Sunitinib—TYK2—cerebellum—hypothyroidism	0.000242	0.000505	CbGeAlD
Sunitinib—SLK—testis—hypothyroidism	0.000242	0.000504	CbGeAlD
Sunitinib—RPS6KB1—liver—hypothyroidism	0.00024	0.0005	CbGeAlD
Sunitinib—FGFR2—testis—hypothyroidism	0.00024	0.0005	CbGeAlD
Sunitinib—YES1—female gonad—hypothyroidism	0.000239	0.000499	CbGeAlD
Sunitinib—IRAK1—cerebellum—hypothyroidism	0.000239	0.000498	CbGeAlD
Sunitinib—FGR—liver—hypothyroidism	0.000239	0.000497	CbGeAlD
Sunitinib—JAK2—testis—hypothyroidism	0.000239	0.000497	CbGeAlD
Sunitinib—AXL—liver—hypothyroidism	0.000238	0.000495	CbGeAlD
Sunitinib—STK10—female gonad—hypothyroidism	0.000237	0.000494	CbGeAlD
Sunitinib—TAOK3—female gonad—hypothyroidism	0.000236	0.000493	CbGeAlD
Sunitinib—FYN—testis—hypothyroidism	0.000235	0.00049	CbGeAlD
Sunitinib—PDGFRA—female gonad—hypothyroidism	0.000235	0.000489	CbGeAlD
Sunitinib—RPS6KB1—cerebellum—hypothyroidism	0.000234	0.000489	CbGeAlD
Sunitinib—RET—cerebellum—hypothyroidism	0.000233	0.000486	CbGeAlD
Sunitinib—AXL—cerebellum—hypothyroidism	0.000232	0.000484	CbGeAlD
Sunitinib—KIT—gonad—hypothyroidism	0.000231	0.000481	CbGeAlD
Sunitinib—MAP4K5—testis—hypothyroidism	0.00023	0.000479	CbGeAlD
Sunitinib—MAP3K3—testis—hypothyroidism	0.00023	0.000479	CbGeAlD
Sunitinib—SLK—liver—hypothyroidism	0.000229	0.000477	CbGeAlD
Sunitinib—CYP3A7—liver—hypothyroidism	0.000228	0.000475	CbGeAlD
Sunitinib—KDR—adrenal gland—hypothyroidism	0.000227	0.000474	CbGeAlD
Sunitinib—MAP2K5—adrenal gland—hypothyroidism	0.000227	0.000474	CbGeAlD
Sunitinib—MAP2K5—blood—hypothyroidism	0.000227	0.000473	CbGeAlD
Sunitinib—KDR—blood—hypothyroidism	0.000227	0.000473	CbGeAlD
Sunitinib—FGFR2—liver—hypothyroidism	0.000227	0.000472	CbGeAlD
Sunitinib—PDGFRB—gonad—hypothyroidism	0.000226	0.00047	CbGeAlD
Sunitinib—JAK2—liver—hypothyroidism	0.000225	0.00047	CbGeAlD
Sunitinib—KIT—pituitary gland—hypothyroidism	0.000225	0.00047	CbGeAlD
Sunitinib—SLK—cerebellum—hypothyroidism	0.000223	0.000466	CbGeAlD
Sunitinib—FYN—liver—hypothyroidism	0.000222	0.000464	CbGeAlD
Sunitinib—FLT1—testis—hypothyroidism	0.000222	0.000463	CbGeAlD
Sunitinib—CSF1R—adrenal gland—hypothyroidism	0.000222	0.000462	CbGeAlD
Sunitinib—CSF1R—blood—hypothyroidism	0.000222	0.000462	CbGeAlD
Sunitinib—FGFR2—cerebellum—hypothyroidism	0.000221	0.000462	CbGeAlD
Sunitinib—JAK2—cerebellum—hypothyroidism	0.00022	0.000459	CbGeAlD
Sunitinib—PDGFRB—pituitary gland—hypothyroidism	0.00022	0.000459	CbGeAlD
Sunitinib—EPHB6—testis—hypothyroidism	0.00022	0.000458	CbGeAlD
Sunitinib—KDR—thyroid gland—hypothyroidism	0.000219	0.000457	CbGeAlD
Sunitinib—MAP2K5—thyroid gland—hypothyroidism	0.000219	0.000457	CbGeAlD
Sunitinib—MAP3K3—liver—hypothyroidism	0.000217	0.000453	CbGeAlD
Sunitinib—MAP4K5—liver—hypothyroidism	0.000217	0.000453	CbGeAlD
Sunitinib—FYN—cerebellum—hypothyroidism	0.000217	0.000453	CbGeAlD
Sunitinib—CSF1R—thyroid gland—hypothyroidism	0.000214	0.000446	CbGeAlD
Sunitinib—MAP4K5—cerebellum—hypothyroidism	0.000212	0.000443	CbGeAlD
Sunitinib—MAP3K3—cerebellum—hypothyroidism	0.000212	0.000443	CbGeAlD
Sunitinib—YES1—testis—hypothyroidism	0.000212	0.000443	CbGeAlD
Sunitinib—KDR—female gonad—hypothyroidism	0.000212	0.000442	CbGeAlD
Sunitinib—MAP2K5—female gonad—hypothyroidism	0.000212	0.000442	CbGeAlD
Sunitinib—STK10—testis—hypothyroidism	0.00021	0.000439	CbGeAlD
Sunitinib—FLT1—liver—hypothyroidism	0.00021	0.000438	CbGeAlD
Sunitinib—ABCC4—heart—hypothyroidism	0.00021	0.000437	CbGeAlD
Sunitinib—TAOK3—testis—hypothyroidism	0.00021	0.000437	CbGeAlD
Sunitinib—PDGFRA—testis—hypothyroidism	0.000208	0.000434	CbGeAlD
Sunitinib—CSF1R—female gonad—hypothyroidism	0.000207	0.000431	CbGeAlD
Sunitinib—FLT1—cerebellum—hypothyroidism	0.000205	0.000428	CbGeAlD
Sunitinib—EPHB6—cerebellum—hypothyroidism	0.000203	0.000423	CbGeAlD
Sunitinib—KIT—adrenal gland—hypothyroidism	0.000201	0.00042	CbGeAlD
Sunitinib—KIT—blood—hypothyroidism	0.000201	0.00042	CbGeAlD
Sunitinib—YES1—liver—hypothyroidism	0.000201	0.000418	CbGeAlD
Sunitinib—STK10—liver—hypothyroidism	0.000199	0.000415	CbGeAlD
Sunitinib—TAOK3—liver—hypothyroidism	0.000198	0.000413	CbGeAlD
Sunitinib—PDGFRA—liver—hypothyroidism	0.000197	0.00041	CbGeAlD
Sunitinib—PDGFRB—adrenal gland—hypothyroidism	0.000197	0.00041	CbGeAlD
Sunitinib—PDGFRB—blood—hypothyroidism	0.000197	0.00041	CbGeAlD
Sunitinib—YES1—cerebellum—hypothyroidism	0.000196	0.000409	CbGeAlD
Sunitinib—STK10—cerebellum—hypothyroidism	0.000194	0.000405	CbGeAlD
Sunitinib—KIT—thyroid gland—hypothyroidism	0.000194	0.000405	CbGeAlD
Sunitinib—CYP3A7-CYP3A51P—liver—hypothyroidism	0.000194	0.000404	CbGeAlD
Sunitinib—TAOK3—cerebellum—hypothyroidism	0.000194	0.000403	CbGeAlD
Sunitinib—PDGFRA—cerebellum—hypothyroidism	0.000192	0.000401	CbGeAlD
Sunitinib—PDGFRB—thyroid gland—hypothyroidism	0.00019	0.000396	CbGeAlD
Sunitinib—MAP2K5—testis—hypothyroidism	0.000188	0.000392	CbGeAlD
Sunitinib—KDR—testis—hypothyroidism	0.000188	0.000392	CbGeAlD
Sunitinib—KIT—female gonad—hypothyroidism	0.000188	0.000391	CbGeAlD
Sunitinib—CSF1R—testis—hypothyroidism	0.000183	0.000382	CbGeAlD
Sunitinib—PDGFRB—female gonad—hypothyroidism	0.000183	0.000382	CbGeAlD
Sunitinib—KDR—liver—hypothyroidism	0.000178	0.00037	CbGeAlD
Sunitinib—MAP2K5—liver—hypothyroidism	0.000178	0.00037	CbGeAlD
Sunitinib—KDR—cerebellum—hypothyroidism	0.000174	0.000362	CbGeAlD
Sunitinib—MAP2K5—cerebellum—hypothyroidism	0.000174	0.000362	CbGeAlD
Sunitinib—CSF1R—liver—hypothyroidism	0.000173	0.000361	CbGeAlD
Sunitinib—CSF1R—cerebellum—hypothyroidism	0.000169	0.000353	CbGeAlD
Sunitinib—KIT—testis—hypothyroidism	0.000166	0.000347	CbGeAlD
Sunitinib—KCNH2—heart—hypothyroidism	0.000166	0.000347	CbGeAlD
Sunitinib—PDGFRB—testis—hypothyroidism	0.000163	0.000339	CbGeAlD
Sunitinib—KIT—liver—hypothyroidism	0.000157	0.000328	CbGeAlD
Sunitinib—KCNH2—cardiovascular system—hypothyroidism	0.000157	0.000327	CbGeAlD
Sunitinib—ABCC4—adrenal gland—hypothyroidism	0.000157	0.000326	CbGeAlD
Sunitinib—ABCC4—blood—hypothyroidism	0.000157	0.000326	CbGeAlD
Sunitinib—KIT—cerebellum—hypothyroidism	0.000154	0.000321	CbGeAlD
Sunitinib—PDGFRB—liver—hypothyroidism	0.000154	0.00032	CbGeAlD
Sunitinib—ABCG2—adrenal cortex—hypothyroidism	0.000153	0.000319	CbGeAlD
Sunitinib—ABCC2—adrenal gland—hypothyroidism	0.000152	0.000316	CbGeAlD
Sunitinib—ABCC2—blood—hypothyroidism	0.000152	0.000316	CbGeAlD
Sunitinib—ABCC4—thyroid gland—hypothyroidism	0.000151	0.000315	CbGeAlD
Sunitinib—PDGFRB—cerebellum—hypothyroidism	0.00015	0.000313	CbGeAlD
Sunitinib—ABCG2—heart—hypothyroidism	0.000148	0.000309	CbGeAlD
Sunitinib—ABCC4—female gonad—hypothyroidism	0.000146	0.000304	CbGeAlD
Sunitinib—KCNH2—pituitary gland—hypothyroidism	0.000139	0.00029	CbGeAlD
Sunitinib—ABCC4—testis—hypothyroidism	0.000129	0.00027	CbGeAlD
Sunitinib—ABCC2—testis—hypothyroidism	0.000125	0.000261	CbGeAlD
Sunitinib—KCNH2—adrenal gland—hypothyroidism	0.000124	0.000259	CbGeAlD
Sunitinib—KCNH2—blood—hypothyroidism	0.000124	0.000259	CbGeAlD
Sunitinib—ABCG2—pituitary gland—hypothyroidism	0.000124	0.000258	CbGeAlD
Sunitinib—ABCC4—liver—hypothyroidism	0.000122	0.000255	CbGeAlD
Sunitinib—ABCC2—liver—hypothyroidism	0.000118	0.000247	CbGeAlD
Sunitinib—KCNH2—female gonad—hypothyroidism	0.000116	0.000241	CbGeAlD
Sunitinib—ABCG2—adrenal gland—hypothyroidism	0.000111	0.00023	CbGeAlD
Sunitinib—ABCG2—blood—hypothyroidism	0.00011	0.00023	CbGeAlD
Sunitinib—ABCG2—thyroid gland—hypothyroidism	0.000107	0.000222	CbGeAlD
Sunitinib—ABCG2—female gonad—hypothyroidism	0.000103	0.000215	CbGeAlD
Sunitinib—KCNH2—testis—hypothyroidism	0.000103	0.000214	CbGeAlD
Sunitinib—CYP3A5—blood—hypothyroidism	0.000103	0.000214	CbGeAlD
Sunitinib—CYP3A5—female gonad—hypothyroidism	9.57e-05	0.000199	CbGeAlD
Sunitinib—KCNH2—cerebellum—hypothyroidism	9.49e-05	0.000198	CbGeAlD
Sunitinib—ABCG2—testis—hypothyroidism	9.14e-05	0.000191	CbGeAlD
Sunitinib—ABCG2—liver—hypothyroidism	8.64e-05	0.00018	CbGeAlD
Sunitinib—ABCG2—cerebellum—hypothyroidism	8.44e-05	0.000176	CbGeAlD
Sunitinib—CYP3A5—liver—hypothyroidism	8.02e-05	0.000167	CbGeAlD
Sunitinib—CYP3A4—blood—hypothyroidism	7.7e-05	0.00016	CbGeAlD
Sunitinib—ABCB1—adrenal cortex—hypothyroidism	7.55e-05	0.000157	CbGeAlD
Sunitinib—ABCB1—heart—hypothyroidism	7.3e-05	0.000152	CbGeAlD
Sunitinib—ABCB1—cardiovascular system—hypothyroidism	6.89e-05	0.000144	CbGeAlD
Sunitinib—ABCB1—gonad—hypothyroidism	6.25e-05	0.00013	CbGeAlD
Sunitinib—ABCB1—pituitary gland—hypothyroidism	6.1e-05	0.000127	CbGeAlD
Sunitinib—CYP3A4—liver—hypothyroidism	6.02e-05	0.000125	CbGeAlD
Sunitinib—ABCB1—adrenal gland—hypothyroidism	5.45e-05	0.000114	CbGeAlD
Sunitinib—ABCB1—blood—hypothyroidism	5.45e-05	0.000114	CbGeAlD
Sunitinib—ABCB1—thyroid gland—hypothyroidism	5.26e-05	0.00011	CbGeAlD
Sunitinib—ABCB1—female gonad—hypothyroidism	5.08e-05	0.000106	CbGeAlD
Sunitinib—ABCB1—testis—hypothyroidism	4.51e-05	9.39e-05	CbGeAlD
Sunitinib—ABCB1—liver—hypothyroidism	4.26e-05	8.88e-05	CbGeAlD
Sunitinib—ABCB1—cerebellum—hypothyroidism	4.16e-05	8.68e-05	CbGeAlD
Sunitinib—PRKAA1—Signaling Pathways—PRL—hypothyroidism	3.17e-05	0.000104	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—POMC—hypothyroidism	3.15e-05	0.000104	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TSHB—hypothyroidism	3.15e-05	0.000104	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TSHR—hypothyroidism	3.15e-05	0.000104	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—IGF1—hypothyroidism	3.14e-05	0.000103	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—PRL—hypothyroidism	3.14e-05	0.000103	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—AVP—hypothyroidism	3.14e-05	0.000103	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—VAV3—hypothyroidism	3.12e-05	0.000103	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—PRL—hypothyroidism	3.12e-05	0.000103	CbGpPWpGaD
Sunitinib—KIT—Immune System—PRL—hypothyroidism	3.12e-05	0.000103	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TSHR—hypothyroidism	3.11e-05	0.000102	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TSHB—hypothyroidism	3.11e-05	0.000102	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—POMC—hypothyroidism	3.1e-05	0.000102	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—POMC—hypothyroidism	3.1e-05	0.000102	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CLTC—hypothyroidism	3.09e-05	0.000102	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—VAV3—hypothyroidism	3.07e-05	0.000101	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—IGF1—hypothyroidism	3.07e-05	0.000101	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—POMC—hypothyroidism	3.06e-05	0.000101	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TSHB—hypothyroidism	3.05e-05	0.0001	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TSHB—hypothyroidism	3.05e-05	0.0001	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TSHR—hypothyroidism	3.05e-05	0.0001	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TSHR—hypothyroidism	3.05e-05	0.0001	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—SH2B3—hypothyroidism	3.04e-05	0.0001	CbGpPWpGaD
Sunitinib—ABCG2—Transmembrane transport of small molecules—AVP—hypothyroidism	3.04e-05	0.0001	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—AVP—hypothyroidism	3.01e-05	9.91e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—POMC—hypothyroidism	3.01e-05	9.91e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ATP5O—hypothyroidism	3e-05	9.89e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TRH—hypothyroidism	2.99e-05	9.84e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—IGF1—hypothyroidism	2.99e-05	9.83e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—IGF1—hypothyroidism	2.99e-05	9.83e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—VAV3—hypothyroidism	2.98e-05	9.79e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—PRL—hypothyroidism	2.97e-05	9.77e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—PRL—hypothyroidism	2.96e-05	9.74e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—PRL—hypothyroidism	2.95e-05	9.72e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—VAV3—hypothyroidism	2.94e-05	9.67e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—PRL—hypothyroidism	2.93e-05	9.65e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—VAV3—hypothyroidism	2.93e-05	9.65e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TRH—hypothyroidism	2.92e-05	9.61e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—VAV3—hypothyroidism	2.9e-05	9.56e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—IGF1—hypothyroidism	2.9e-05	9.53e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TSHB—hypothyroidism	2.9e-05	9.53e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TSHR—hypothyroidism	2.9e-05	9.53e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—SH2B3—hypothyroidism	2.89e-05	9.5e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TSHB—hypothyroidism	2.89e-05	9.5e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TSHR—hypothyroidism	2.89e-05	9.5e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—VAV3—hypothyroidism	2.89e-05	9.5e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—VAV3—hypothyroidism	2.89e-05	9.5e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—PRL—hypothyroidism	2.88e-05	9.48e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—PRL—hypothyroidism	2.88e-05	9.47e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—TPO—hypothyroidism	2.82e-05	9.3e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—AVP—hypothyroidism	2.82e-05	9.29e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TRH—hypothyroidism	2.81e-05	9.26e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—SH2B3—hypothyroidism	2.8e-05	9.23e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—AVP—hypothyroidism	2.8e-05	9.21e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TRH—hypothyroidism	2.8e-05	9.21e-05	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—IGF1—hypothyroidism	2.79e-05	9.17e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—POMC—hypothyroidism	2.78e-05	9.14e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—POMC—hypothyroidism	2.78e-05	9.14e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—PRL—hypothyroidism	2.77e-05	9.12e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—SH2B3—hypothyroidism	2.77e-05	9.11e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—VAV3—hypothyroidism	2.76e-05	9.09e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—PRL—hypothyroidism	2.75e-05	9.06e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—VAV3—hypothyroidism	2.74e-05	9.01e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—PRL—hypothyroidism	2.73e-05	9e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—VAV3—hypothyroidism	2.73e-05	8.99e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—PRL—hypothyroidism	2.73e-05	8.97e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—PRL—hypothyroidism	2.73e-05	8.97e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—SH2B3—hypothyroidism	2.72e-05	8.95e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—SH2B3—hypothyroidism	2.72e-05	8.95e-05	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—VAV3—hypothyroidism	2.72e-05	8.95e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TRH—hypothyroidism	2.67e-05	8.8e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—IGF1—hypothyroidism	2.67e-05	8.79e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—PRL—hypothyroidism	2.67e-05	8.79e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—PRL—hypothyroidism	2.67e-05	8.79e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TSHB—hypothyroidism	2.67e-05	8.77e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TSHR—hypothyroidism	2.67e-05	8.77e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—VAV3—hypothyroidism	2.66e-05	8.76e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—PRL—hypothyroidism	2.66e-05	8.76e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—AVP—hypothyroidism	2.66e-05	8.75e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	2.65e-05	8.72e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—IGF1—hypothyroidism	2.65e-05	8.72e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—POMC—hypothyroidism	2.63e-05	8.64e-05	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—AVP—hypothyroidism	2.62e-05	8.62e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TSHB—hypothyroidism	2.6e-05	8.56e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—PRL—hypothyroidism	2.6e-05	8.56e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TSHR—hypothyroidism	2.6e-05	8.56e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—POMC—hypothyroidism	2.6e-05	8.55e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—VAV3—hypothyroidism	2.58e-05	8.5e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—SH2B3—hypothyroidism	2.58e-05	8.49e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—SH2B3—hypothyroidism	2.57e-05	8.47e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—PRL—hypothyroidism	2.56e-05	8.44e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—AVP—hypothyroidism	2.56e-05	8.44e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—VAV3—hypothyroidism	2.56e-05	8.44e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—PRL—hypothyroidism	2.55e-05	8.4e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—VAV3—hypothyroidism	2.55e-05	8.38e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—IGF1—hypothyroidism	2.53e-05	8.31e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—VAV3—hypothyroidism	2.52e-05	8.3e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—PRL—hypothyroidism	2.52e-05	8.28e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TSHB—hypothyroidism	2.51e-05	8.25e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TSHR—hypothyroidism	2.51e-05	8.25e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—IGF1—hypothyroidism	2.5e-05	8.23e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TSHR—hypothyroidism	2.49e-05	8.21e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TSHB—hypothyroidism	2.49e-05	8.21e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AVP—hypothyroidism	2.49e-05	8.19e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—POMC—hypothyroidism	2.48e-05	8.15e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—VAV3—hypothyroidism	2.47e-05	8.13e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AVP—hypothyroidism	2.47e-05	8.13e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—VAV3—hypothyroidism	2.47e-05	8.13e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—VAV3—hypothyroidism	2.47e-05	8.12e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—VAV3—hypothyroidism	2.46e-05	8.1e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—PRL—hypothyroidism	2.46e-05	8.08e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AVP—hypothyroidism	2.45e-05	8.08e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—PRL—hypothyroidism	2.44e-05	8.02e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—TSHB—hypothyroidism	2.42e-05	7.96e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—VAV3—hypothyroidism	2.41e-05	7.92e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—TSHB—hypothyroidism	2.4e-05	7.89e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TSHB—hypothyroidism	2.38e-05	7.84e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TSHR—hypothyroidism	2.38e-05	7.84e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—IGF1—hypothyroidism	2.38e-05	7.84e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AVP—hypothyroidism	2.38e-05	7.83e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AVP—hypothyroidism	2.38e-05	7.83e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AVP—hypothyroidism	2.38e-05	7.83e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—SH2B3—hypothyroidism	2.38e-05	7.82e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—VAV3—hypothyroidism	2.37e-05	7.81e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—PRL—hypothyroidism	2.37e-05	7.79e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—VAV3—hypothyroidism	2.36e-05	7.77e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PRL—hypothyroidism	2.36e-05	7.75e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—POMC—hypothyroidism	2.33e-05	7.68e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—SH2B3—hypothyroidism	2.32e-05	7.63e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AVP—hypothyroidism	2.32e-05	7.63e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—POMC—hypothyroidism	2.32e-05	7.62e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—PRL—hypothyroidism	2.26e-05	7.43e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—VAV3—hypothyroidism	2.26e-05	7.42e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—PRL—hypothyroidism	2.25e-05	7.41e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—IGF1—hypothyroidism	2.25e-05	7.39e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SH2B3—hypothyroidism	2.24e-05	7.36e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—IGF1—hypothyroidism	2.23e-05	7.33e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SH2B3—hypothyroidism	2.22e-05	7.32e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—IYD—hypothyroidism	2.18e-05	7.16e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PIK3C2A—hypothyroidism	2.16e-05	7.09e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—PRL—hypothyroidism	2.14e-05	7.05e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	2.14e-05	7.03e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SH2B3—hypothyroidism	2.12e-05	6.99e-05	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.09e-05	6.88e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—VAV3—hypothyroidism	2.09e-05	6.88e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—POMC—hypothyroidism	2.09e-05	6.86e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—PRL—hypothyroidism	2.08e-05	6.84e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PRL—hypothyroidism	2.05e-05	6.76e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PRL—hypothyroidism	2.02e-05	6.64e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PRL—hypothyroidism	2.02e-05	6.64e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AVP—hypothyroidism	2.01e-05	6.63e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—POMC—hypothyroidism	2e-05	6.58e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—VAV3—hypothyroidism	1.98e-05	6.52e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—IGF1—hypothyroidism	1.92e-05	6.33e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—VAV3—hypothyroidism	1.92e-05	6.33e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PRL—hypothyroidism	1.91e-05	6.3e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PRL—hypothyroidism	1.91e-05	6.28e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AVP—hypothyroidism	1.91e-05	6.28e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—VAV3—hypothyroidism	1.9e-05	6.25e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—POMC—hypothyroidism	1.88e-05	6.18e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—VAV3—hypothyroidism	1.87e-05	6.14e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—VAV3—hypothyroidism	1.87e-05	6.14e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—POMC—hypothyroidism	1.86e-05	6.12e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AVP—hypothyroidism	1.85e-05	6.1e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ATP5O—hypothyroidism	1.85e-05	6.09e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Biological oxidations—POMC—hypothyroidism	1.85e-05	6.07e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AVP—hypothyroidism	1.83e-05	6.02e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—SLC5A5—hypothyroidism	1.81e-05	5.96e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IGF1—hypothyroidism	1.81e-05	5.94e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AVP—hypothyroidism	1.8e-05	5.92e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AVP—hypothyroidism	1.8e-05	5.92e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—SLC5A5—hypothyroidism	1.79e-05	5.91e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IGF1—hypothyroidism	1.79e-05	5.89e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—VAV3—hypothyroidism	1.77e-05	5.83e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—POMC—hypothyroidism	1.77e-05	5.82e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—VAV3—hypothyroidism	1.77e-05	5.81e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PRL—hypothyroidism	1.76e-05	5.8e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TPO—hypothyroidism	1.74e-05	5.73e-05	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—POMC—hypothyroidism	1.74e-05	5.73e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—TSHB—hypothyroidism	1.73e-05	5.7e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PRL—hypothyroidism	1.72e-05	5.66e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AVP—hypothyroidism	1.71e-05	5.62e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—POMC—hypothyroidism	1.7e-05	5.61e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AVP—hypothyroidism	1.7e-05	5.6e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PRL—hypothyroidism	1.66e-05	5.46e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—POMC—hypothyroidism	1.65e-05	5.44e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PRL—hypothyroidism	1.65e-05	5.43e-05	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.65e-05	5.42e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—POMC—hypothyroidism	1.64e-05	5.4e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IGF1—hypothyroidism	1.64e-05	5.39e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VAV3—hypothyroidism	1.63e-05	5.37e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—POMC—hypothyroidism	1.63e-05	5.37e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VAV3—hypothyroidism	1.59e-05	5.24e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—POMC—hypothyroidism	1.58e-05	5.2e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—POMC—hypothyroidism	1.58e-05	5.2e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—POMC—hypothyroidism	1.58e-05	5.2e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IGF1—hypothyroidism	1.58e-05	5.2e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PRL—hypothyroidism	1.58e-05	5.19e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AVP—hypothyroidism	1.57e-05	5.17e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IGF1—hypothyroidism	1.57e-05	5.16e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	1.54e-05	5.08e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—POMC—hypothyroidism	1.54e-05	5.07e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VAV3—hypothyroidism	1.53e-05	5.05e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AVP—hypothyroidism	1.53e-05	5.05e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VAV3—hypothyroidism	1.53e-05	5.02e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IGF1—hypothyroidism	1.52e-05	5.01e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IGF1—hypothyroidism	1.52e-05	5.01e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IGF1—hypothyroidism	1.48e-05	4.88e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AVP—hypothyroidism	1.48e-05	4.86e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AVP—hypothyroidism	1.47e-05	4.84e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VAV3—hypothyroidism	1.46e-05	4.8e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AVP—hypothyroidism	1.4e-05	4.62e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—POMC—hypothyroidism	1.34e-05	4.4e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—TSHB—hypothyroidism	1.31e-05	4.3e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—SLC5A5—hypothyroidism	1.3e-05	4.27e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IGF1—hypothyroidism	1.29e-05	4.24e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—POMC—hypothyroidism	1.27e-05	4.18e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—POMC—hypothyroidism	1.23e-05	4.05e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IGF1—hypothyroidism	1.22e-05	4.02e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—POMC—hypothyroidism	1.22e-05	4e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—POMC—hypothyroidism	1.19e-05	3.93e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—POMC—hypothyroidism	1.19e-05	3.93e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IGF1—hypothyroidism	1.19e-05	3.9e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IGF1—hypothyroidism	1.17e-05	3.85e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.17e-05	3.84e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IGF1—hypothyroidism	1.15e-05	3.78e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IGF1—hypothyroidism	1.15e-05	3.78e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—POMC—hypothyroidism	1.13e-05	3.73e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—POMC—hypothyroidism	1.13e-05	3.72e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IGF1—hypothyroidism	1.09e-05	3.59e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IGF1—hypothyroidism	1.09e-05	3.58e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—POMC—hypothyroidism	1.04e-05	3.44e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—POMC—hypothyroidism	1.02e-05	3.35e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IGF1—hypothyroidism	1e-05	3.31e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—POMC—hypothyroidism	9.82e-06	3.23e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IGF1—hypothyroidism	9.8e-06	3.23e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—SLC5A5—hypothyroidism	9.79e-06	3.22e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—POMC—hypothyroidism	9.77e-06	3.21e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—POMC—hypothyroidism	9.47e-06	3.12e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IGF1—hypothyroidism	9.45e-06	3.11e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IGF1—hypothyroidism	9.4e-06	3.09e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—POMC—hypothyroidism	9.39e-06	3.09e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—POMC—hypothyroidism	9.34e-06	3.07e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IGF1—hypothyroidism	8.98e-06	2.96e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TSHB—hypothyroidism	8.06e-06	2.65e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	7.18e-06	2.36e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—POMC—hypothyroidism	6.79e-06	2.23e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC5A5—hypothyroidism	6.03e-06	1.98e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—POMC—hypothyroidism	5.12e-06	1.69e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—POMC—hypothyroidism	3.16e-06	1.04e-05	CbGpPWpGaD
